CSF and plasma proteomic insights into the pathophysiology of cerebral small vessel disease and cerebrovascular event risk prediction

Abstract

Background: Cerebral small vessel disease (cSVD) is the leading vascular contributor to dementia and stroke, with white matter lesions (WML) as the most common manifestation. Despite its prevalence, the underlying pathophysiology remains poorly understood, and reliable plasma biomarkers are lacking.